A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT00652366 · COMPLETED
Trial details
- NCT number
- NCT00652366
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2012-02-01
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.